New Product in Turkey Market: Cold Beverages with Hemp Extract
Objective: Turkey is important tea markets in the world and ice tea is one of the most popular products in the recent years. In this study, we aimed to evaluated ingredients of the substances written on the can of "Cannabis Ice Tea"; which is presented as psychoactive substance cannabis positive.
Materials and Methods: The drink was analyzed by immunoassay and chromatographic methods whether it contains prohibited substance under the relevant legal regulations. In the immunoassay studies; cannabis, cocaine, amphetamines, synthetic cannabinoids, opiates and benzodiazepine groups were analyzed. Cannabis, amphetamines and derivatives, analgesics/nonsteroidal anti-inflammatory drugs (NSAID), antidepressants, antihypertensives, hypnotics/sedatives, neuroleptics, opiates/opioids and caffeine were analyzed by Gas Chromatography-Mass Spectrometry.
Results: “Cannabis Ice Tea” was analyzed by immunoassay and parameter results were determined to be negative according to cut off values. The obtained analysis results by chromatographic method; cannabis, amphetamines and derivatives, analgesics/NSAIDs, antidepressants, antihypertensives, hypnotics/sedatives, neuroleptics, opiates/opioids were negative, while caffeine was positive (62 µg/mL).
Discussion and Conclusion: Cannabis Ice Tea, which has a big market in the world and is canceled in our country, sales policy for product named as followed by exaggerated taste and sense descriptions. According to the analytical results; caffeine-containing beverage was not containing any cannabis or another prohibited psychoactive substance, can create a potential incentive effect that suggests the use of cannabis in the subconscious mind with a hemp similar logo on ice. In general hemp plant, known to contain psychoactive substances, is required to increased awareness of the use of visuals in sales and necessary legal arrangements, studies and inspections.
https://www.carrefoursa.com/d/c-swiss-kenevirli-soguk-cay-250-ml Erişim Tarihi: 14.03.2017
http://www.seagull.at/en/pictures2 Erişim Tarihi: 14.03.2017
West D.P., Hemp and Marijuana:Myths & Realities, 1998 North American Industrial Hemp Council, Inc.
Gürel A., Akdemir H., Emiroglu S.H., Kadoglu, H., Karadayı, H.B., Türkiye Lif Bitkileri (Pamuk Tarımı, Teknolojisine Genel Bakış ve Diğer Lif Bitkileri). Türkiye Ziraat Mühendisliği V Teknik Kongresi, 17-21 Ocak 2000, Ankara, 525- 566.
Brenneisen R., Chemistry and Analysis of Phytocannabinoids and Other Cannabis Constituents, Chapter 2, 17-49, ElSohly M. A, editor, Marijuana and the Cannabinoids, Humana Press, Totowa, New Jersey, 2007
Akgür S., Esrar ve Kannabinoidler, 93-107, Akgür S.,Coşkunol H. editors, Bağımlılık Yapıcı Maddeler ve Toksikolojisi, Ege Üniversitesi Madde Bağımlılığı, Toksikoloji ve İlaç Bilimleri Enstitüsü Yayınları No:3, 2014,
Wright, Andrew, Wisconsin's Hemp Industry. Wisconsin Agricultural Experiment Station Bulletin, 1918, 293. p.5
Uluğ B., Gürel Ş. C., Esrar (Kannabis) Kullanımına Bağlı Ruhsal Ve Davranışsal Bozukluklar, 141-145, Bölüm 7, Madde Bağımlılığı Tanı El Kitabı
Huestis M. A., Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770-1804
Haney M., Effects of smoked marijuana in healthy and HIV + marijuana smokers. J Clin Pharmacol 2002;42(Suppl 11):S34-S40 doi: 10.1002/j.1552-4604.2002.tb06001.x
Uzbay T., Madde bağımlılığı tüm boyutlarıyla bağımlılık ve bağımlılık yapıcı maddeler, İstanbul medikal sağlık ve yayıncılık, Bölüm 2:Esrar Bağımlılığı, 203-225
Avrupa Uyuşturucu ve Uyuşturucu Bağımlılığı İzleme Merkez, Avrupa Uyuşturucu Raporu, 2016
Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı, Türkiye Uyuşturucu Raporu, 2013
http://sunrisemanagement.com/wordpress/wp-content/uploads/2011/11/C+SWISS-deck.pdf Erişim Tarihi: 14.03.2017
Vangikar H., Workplace drug testing, pharmaceutical press, Verstraete A., Interpretation of urine drug test results by the medical review officer, 2011, 293-330
http://www.seagull.at/en/pictures2/picfolder-dubai-promotion-sponsoring Erişim Tarihi: 14.03.2017
Copyright (c) 2017 Melike Aydoğdu, Rukiye Döğer, Serap Annette Akgür
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Bulletin of Legal Medicine is an open access scientific journal. Open access means that all content is freely available without charge to the user or his/her institution on the principle that making research freely available to the public supports a greater global exchange of knowledge. The Journal and content of this website is licensed under the terms of the Creative Commons Attribution (CC BY) License. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.
The Creative Commons Attribution License (CC BY) allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
The Bulletin of Legal Medicine requires the author as the rights holder to sign and submit the journal's agreement form prior to acceptance. The authors retain copyright of their work and grant the Association for its publication. This ensures both that The Journal has the right to publish the article and that the author has confirmed various things including that it is their original work and that it is based on valid research.
Authors who publish with this journal agree to the following terms:
*Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
*Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
*Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.